DE2554453A1 - Medikament zur glykaemieregulierung - Google Patents

Medikament zur glykaemieregulierung

Info

Publication number
DE2554453A1
DE2554453A1 DE19752554453 DE2554453A DE2554453A1 DE 2554453 A1 DE2554453 A1 DE 2554453A1 DE 19752554453 DE19752554453 DE 19752554453 DE 2554453 A DE2554453 A DE 2554453A DE 2554453 A1 DE2554453 A1 DE 2554453A1
Authority
DE
Germany
Prior art keywords
guanosine
insulin
boehmert
glucose
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752554453
Other languages
German (de)
English (en)
Inventor
Henri Dr Laborit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EXPERIMENTALES ET CLINIQUES DE
Original Assignee
EXPERIMENTALES ET CLINIQUES DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EXPERIMENTALES ET CLINIQUES DE filed Critical EXPERIMENTALES ET CLINIQUES DE
Publication of DE2554453A1 publication Critical patent/DE2554453A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752554453 1974-12-18 1975-12-04 Medikament zur glykaemieregulierung Pending DE2554453A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5458274 1974-12-18

Publications (1)

Publication Number Publication Date
DE2554453A1 true DE2554453A1 (de) 1976-06-24

Family

ID=10471478

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752554453 Pending DE2554453A1 (de) 1974-12-18 1975-12-04 Medikament zur glykaemieregulierung

Country Status (3)

Country Link
US (1) US4035486A (enExample)
DE (1) DE2554453A1 (enExample)
FR (1) FR2294712A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722324A4 (en) * 1993-08-24 1999-06-16 Hill Medical Corp PHARMACEUTICAL COMPOSITION FOR IMMUNITIMULATING THERAPY
US6143717A (en) * 1993-08-24 2000-11-07 Hill Medical Corporation Pharmaceutical composition and method for immunoenhancement therapy

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729989A (en) * 1985-06-28 1988-03-08 Merck & Co., Inc. Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
WO1996003125A1 (en) 1994-07-25 1996-02-08 Glasky Alvin J Carbon monoxide dependent guanylyl cyclase modifiers
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722324A4 (en) * 1993-08-24 1999-06-16 Hill Medical Corp PHARMACEUTICAL COMPOSITION FOR IMMUNITIMULATING THERAPY
US6143717A (en) * 1993-08-24 2000-11-07 Hill Medical Corporation Pharmaceutical composition and method for immunoenhancement therapy

Also Published As

Publication number Publication date
FR2294712B1 (enExample) 1978-07-28
US4035486A (en) 1977-07-12
FR2294712A1 (fr) 1976-07-16

Similar Documents

Publication Publication Date Title
DE69533940T2 (de) Therapeutische zusammensetzungen von venösdilatoren und arterielldilatoren
DE69429169T2 (de) Pharmazeutisches präparat, das heparin, heparinfragmente oder -derivate in kombination mit glycerinestern enthält
Grob et al. Potassium movement in normal subjects: effect on muscle function
DE2554453A1 (de) Medikament zur glykaemieregulierung
DE2000133A1 (de) Enzymloesung
DE2336401A1 (de) Enzymatisches salz, verfahren zu dessen herstellung und therapeutische mittel, die es enthalten
CH670952A5 (enExample)
Berliner The effect of calcium on the heart
DE2709506A1 (de) Arzneimittel, enthaltend 10-deazaminopterin
DE3843241A1 (de) Nephroprotektive infusionsloesung
DE2013426A1 (en) Zinc chelates of amino acids in diabetes
Hadházy et al. The effects of PGE1 on responses to cardiac vagus nerve stimulation and acetylcholine release
DE2349186C2 (de) Arzneimittel zur Verbesserung der Zellatmung, der Herzmuskelleistung und der Hirnfunktion
DE60024969T2 (de) 2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
DE1805257A1 (de) Diagnostische Zubereitung und Verfahren zu deren Herstellung
DE60219770T2 (de) Krebsmittel
EP0013962A1 (de) Aminosäuren und Mineralsalze enthaltende Infusionslösung
LU84951A1 (de) Arzneimittel mit cytostatischer wirkung
DE1717100A1 (de) Verfahren zur Herstellung von anticarcinomatoesen Praeparaten haemolytischer Streptococcen
DE1293705B (de) Verfahren zur Gewinnung eines elastolytisch wirksamen Bauchspeicheldruesen-Praeparates
DE2518509C3 (de) Pharmazeutisches Mittel für Antitumoraktivität, enthaltend Abrin
DE2657381A1 (de) Glucosehaltigre infusionsloesungen
DE2801867A1 (de) Antikoagulans-arzneimittel auf der basis von heparin
DE2011499A1 (de) Arzneimittel aus Germaniumsäure und Cystein und Verfahren zu seiner Herstellung
DE3203011C2 (de) Verwendung von 2-(3-Dimethylaminopropyl)-5,9-Dimethyl-4,8-Decadiensäure zur Behandlung von Herzerkrankungen

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee